Stock News

FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024
Amgen Inc's Dividend Analysis
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
Sector Superstars: 3 Stocks Generating the Most Buzz on Wall Street
3 Tried and True Dividend Stocks to Buy for Your Portfolio
15 Best S&P 500 Dividend Stocks To Buy Now
Investors Pile Into Amgen in Search of Next Obesity Drug Payout

As seen on...